Clipping vs Coiling for Brain Aneurysm
(MCAAT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to compare two treatments for brain aneurysms located on the middle cerebral artery (MCA). It will examine surgical clipping, which involves placing a clip on the aneurysm, and endovascular methods, which use devices like stents to manage the aneurysm from inside the blood vessel. The goal is to determine which treatment works best for these specific aneurysms. Individuals with a documented aneurysm on the MCA who are suitable for either treatment approach might be a good fit for this trial. As an unphased trial, this study offers participants the opportunity to contribute to important research that could enhance treatment options for future patients.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for more details.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both endovascular and surgical treatments for brain aneurysms have been studied for safety. For endovascular treatments, one study found a 12% chance of complications, including a 2.4% chance of the aneurysm bursting and an 8.5% chance of blood flow blockage. Another study found that the risk of dying in the hospital was 5% or less for aneurysms that hadn't burst.
Surgical treatment, particularly microsurgical clipping, has proven to be quite safe. Specifically, one study reported that almost 98% of patients had good brain function two years after surgery, indicating that most people did well after their operations.
Both treatments carry risks, but they are generally considered safe options for treating brain aneurysms. Discussing with a doctor is crucial to determine which treatment might be best based on individual health needs.12345Why are researchers excited about this trial?
Researchers are excited about the treatments for brain aneurysms in this trial because they offer two distinct approaches: endovascular management and surgical management. Endovascular management, often referred to as "coiling," involves a minimally invasive technique where coils are inserted into the aneurysm via a catheter to prevent it from rupturing. This approach is less invasive than traditional surgery and can lead to quicker recovery times. On the other hand, surgical management, known as "clipping," involves opening the skull to place a clip around the aneurysm, which can provide a more permanent solution. By comparing these two methods, researchers aim to determine which is more effective and safer for patients, potentially leading to better treatment strategies for brain aneurysms.
What evidence suggests that this trial's treatments could be effective for brain aneurysms?
This trial will compare surgical management, such as clipping, with endovascular management for treating brain aneurysms. Research has shown that surgery, like clipping, is often more effective for treating unruptured brain aneurysms. One study found that 97.98% of patients maintained good brain function two years after surgery. Another study found that surgical clipping surpassed endovascular treatments, like coiling, in preventing aneurysm complications. However, endovascular treatments can significantly reduce the risk of rupture, especially in larger aneurysms. While both methods offer benefits, evidence suggests that surgical clipping may provide better results for certain aneurysms.12678
Who Is on the Research Team?
Tim Darsaut
Principal Investigator
University of Alberta Faculty of Medicine and Dentistry
Are You a Good Fit for This Trial?
This trial is for adults with a brain aneurysm located on the middle cerebral artery, which can be treated by surgery or endovascular methods. It includes those with recent or older ruptures (over 30 days old) who are in stable condition (WFNS grade 4 or less). People allergic to contrast material, unable to consent, with AVM-related aneurysms, or severe ruptures (WFNS grade 5) cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either surgical clipping or endovascular management of MCA aneurysms
Follow-up
Participants are monitored for treatment success and safety, including assessments for intracranial hemorrhage and residual aneurysm
Long-term follow-up
Continued monitoring for overall mortality and morbidity
What Are the Treatments Tested in This Trial?
Interventions
- Endovascular management
- Surgical management
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor